SomnoMed Limited (SOMNF)
SomnoMed Limited operates in the Medical - Devices industry of the Healthcare sector, headquartered in Crows Nest, NSW, AU. The stock last traded at $0.45, down 0.00% on the session, giving a market capitalisation of $98.9M. On trailing twelve-month figures it carries a trailing P/E of -33.47, a net margin of -2.2%. Its beta of 0.80 implies it has historically moved less than the broad market.
SomnoMed Limited, together with its subsidiaries, produce and sells devices for the oral treatment of sleep related disorders in the Asia Pacific region, North America, and Europe. It provides SomnoDent Avant, as well as SomnoDent Classic, SomnoDent Flex, and SomnoDent Fusion are offered for the treatment of obstructive sleep apnea. The company also offers SomMorning Repositioner, a product designed to help return patient's mandible back to its pre-treatment centric position; SomnoBrux splint, a custom fit, acrylic splint for patient's upper teeth designed to protect teeth from grinding and scraping during Bruxism; and SomTabs, which are cleaning tablets to clean oral appliances. SomnoMed Limited was incorporated in 1987 and is headquartered in Crows Nest, Australia.
SomnoMed Limited is most often compared with the following Healthcare names: